AxoGen, Inc. (AXGN)
NASDAQ: AXGN · IEX Real-Time Price · USD
6.86
+0.36 (5.54%)
Apr 22, 2024, 4:00 PM EDT - Market closed
AxoGen Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for AxoGen stock have an average target of 13.6, with a low estimate of 9.00 and a high estimate of 20. The average target predicts an increase of 98.25% from the current stock price of 6.86.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 19, 2024.
Analyst Ratings
The average analyst rating for AxoGen stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $12 | Buy | Reiterates | $12 | +74.93% | Jan 19, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +60.35% | Dec 7, 2023 |
| Leerink Partners | Leerink Partners | Buy Initiates $9 | Buy | Initiates | $9 | +31.20% | Oct 16, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $16 | Buy | Reiterates | $16 | +133.24% | Sep 26, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $16 | Buy | Reiterates | $16 | +133.24% | Aug 22, 2023 |
Financial Forecast
Revenue This Year
183.10M
from 159.01M
Increased by 15.15%
Revenue Next Year
206.53M
from 183.10M
Increased by 12.80%
EPS This Year
-0.16
from -0.51
EPS Next Year
0.18
from -0.16
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 189.5M | 215.0M | 242.2M | 294.4M | 338.6M |
| Avg | 183.1M | 206.5M | 230.6M | 274.0M | 309.9M |
| Low | 175.4M | 196.0M | 217.9M | 251.7M | 279.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.2% | 17.4% | 17.3% | 27.7% | 23.6% |
| Avg | 15.1% | 12.8% | 11.7% | 18.8% | 13.1% |
| Low | 10.3% | 7.0% | 5.5% | 9.1% | 2.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.03 | 0.62 | 1.04 | 0.59 | 0.70 |
| Avg | -0.16 | 0.18 | 0.43 | 0.57 | 0.68 |
| Low | -0.31 | -0.04 | 0.19 | 0.55 | 0.66 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 488.0% | 38.1% | 23.2% |
| Avg | - | - | 140.9% | 34.1% | 19.6% |
| Low | - | - | 5.3% | 28.9% | 15.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.